WPI 2233 Pill: white, round, 10mm
The pill with imprint WPI 2233 (White, Round, 10mm) has been identified as Tamoxifen Citrate 20 mg and is used for Breast Cancer, Metastatic, Breast Cancer, Adjuvant, Breast Cancer, Male, Breast Cancer, and Breast Cancer, Palliative. It belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators and is not a controlled substance.
Images for WPI 2233





Tamoxifen Citrate
- Imprint
- WPI 2233
- Strength
- 20 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Hormones/antineoplastics, Selective estrogen receptor modulators
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 00591-2233 (Discontinued)
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
corn starch
Note: Inactive ingredients may vary.
See also:
More about tamoxifen
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (98)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: hormones/antineoplastics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.